| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2010/04/29 | 06:40 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/04/28 | 06:01 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/04/27 | 21:00 | Business Wire | Allos Therapeutics Appoints Dr. Charles Morris as Chief Medical Officer | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/04/21 | 21:00 | Business Wire | Allos Therapeutics to Report First Quarter 2010 Financial Results on May 5, 2010 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/04/15 | 06:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/04/10 | 05:34 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/04/10 | 05:30 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/03/13 | 08:39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/03/12 | 08:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/03/11 | 06:20 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/03/09 | 08:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/03/04 | 08:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/03/02 | 06:46 | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/03/02 | 06:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/03/02 | 06:00 | Business Wire | Allos Therapeutics Reports Fourth Quarter and Full Year 2009 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/27 | 06:18 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/25 | 08:10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/25 | 08:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/25 | 08:05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/25 | 08:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/25 | 07:58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/24 | 23:01 | Business Wire | Allos Therapeutics to Participate in RBC Capital Markets Health Care Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/17 | 22:00 | Business Wire | Allos Therapeutics to Report Fourth Quarter and Full Year 2009 Results on March 1, 2010 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/17 | 07:35 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/17 | 06:49 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/17 | 06:18 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/17 | 02:48 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/11 | 07:50 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/11 | 03:25 | PR Newswire (US) | MedNet Solutions Deploys Global Peripheral T-cell Lymphoma Registry for Allos Therapeutics | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/02/03 | 22:00 | Business Wire | Allos Therapeutics to Present at BIO CEO & Investor Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |